Proton Pump Inhibitors: The Good, Bad, and Ugly

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Proton pump inhibitors (PPIs) are the primary treatment for acid-related disorders.
• Concerns exist regarding the empirical, high-dose, and polypharmacy use of PPIs without clear indications.

Purpose of the Study:

• To outline appropriate clinical indications for PPIs.
• To review significant adverse events associated with PPIs.
• To provide perspective on balancing the benefits and risks of PPI therapy.

Main Methods:

• Literature review and synthesis of current evidence on PPI usage.
• Analysis of clinical guidelines and safety data.
• Discussion of risk-benefit profiles for PPIs.

Main Results:

• PPIs are frequently prescribed without objective diagnosis, leading to potential overutilization.
• Significant adverse events associated with long-term or inappropriate PPI use are identified.
• The safety profile of PPIs is generally favorable when used appropriately.

Conclusions:

• Appropriate patient selection and diagnosis are crucial for effective PPI therapy.
• Careful consideration of PPI benefits versus potential risks is necessary.
• Optimizing PPI prescribing practices can improve patient outcomes and reduce healthcare costs.